Russell Investments Group’s Verona Pharma VRNA Stock Holding History

Russell Investments Group’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16,858	Closed	-$1.8M	–	4268
2025 Q3	$1.8M	Sell	16,858 -124,245	-88%	-$13M	﹤0.01%	1910
2025 Q2	$13.3M	Buy	141,103 +53,701	+61%	+$3.98M	0.02%	730
2025 Q1	$5.55M	Buy	+87,402	New	+$5.23M	0.01%	1107

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Russell Investments Group's VRNA Position: Q4 2025 in Review

Russell Investments Group sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 16,858 shares — an estimated $1.8M sold.

Russell Investments Group first reported a position in VRNA in Q1 2025 and held it in 3 quarters. The position peaked at $13.3M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Russell Investments Group reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Russell Investments Group sold 16,858 Verona Pharma shares in Q4 2025, an estimated $1.8M.
Russell Investments Group first reported a position in Verona Pharma in Q1 2025 and held it in 3 quarters.
Russell Investments Group's Verona Pharma position peaked at $13.3M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Russell Investments Group's 13F filing for Q4 2025, filed 17 Feb 2026.